Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Characterization of Epithelial Ovarian Cancer Patients in Terms of Homologous Recombination Phenotype

This is a prospective observational multi-country, multi-center study of a large real-world cohort of first line (1L) epithelial ovarian cancer patients, exposed to standard of care (SOC) treatment stratified according to BRCA1/2 and HRD status.

Participants needed: 1,000
Trial details
Age: 18-100Biological sex: FemaleType: ObservationalSponsor: Nordic Society of Gynaecological Oncology - Clinical Trials UnitUpdated: Feb 27, 2026Locations: 1Duration: 5 Years
Eligibility criteria

FIGO stage I-II with a known BRCA1/2 mutation (germline/gBRCA or somatic/tBRCA) [+5]

Non-epithelial ovarian cancer, borderline tumors, or mucinous histology [+1]

Status: Recruiting

Palliation in Gynae-oncology: Patients Expectations and Assessment of Care (PEACE)

The overall aim is to assess the feasibility and acceptability of collecting data on the patients and carers perception of care as well as to prospectively monitor end of life care.

Participants needed: 73
Trial details
Age: 18+Biological sex: FemaleType: ObservationalSponsor: Nordic Society of Gynaecological Oncology - Clinical Trials UnitUpdated: Oct 1, 2024Locations: 1Duration: 6 Weeks
Eligibility criteria

Patients with any advanced gynecological malignancy and a life expectancy of app... [+3]

Unable to be comply with the protocol. [+7]